Development of a Thalassemia International Prognostic Scoring System (TIPSS).

Autor: Vitrano A; Campus of Haematology Franco and Piera Cutino, AOOR Villa Sofia-V. Cervello, Palermo, Italy., Musallam KM; Thalassemia Center, Burjeel Medical City, Abu Dhabi, United Arab Emirates., Meloni A; Department of Radiology, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy., Karimi M; Haematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Daar S; Department of Haematology, College of Medicine and Health Sciences, Sultan Qaboos University, Oman; Wallenberg Research Centre, Stellenbosch Institute for Advanced Study, Stellenbosch University, Stellenbosch, South Africa., Ricchi P; Rare Blood Cell Disease Unit, 'Cardarelli' Hospital, Naples, Italy., Costantini S; Rare Blood Cell Disease Unit, 'Cardarelli' Hospital, Naples, Italy., Vlachaki E; Thalassaemia Unit, Ippokratio University Hospital, Thessaloniki, Greece., Di Marco V; Sezione di Gastroenterologia e Epatologia, Dipartimento Biomedico di Medicina Interna e Specialistica, University of Palermo, Palermo, Italy., El-Beshlawy A; Department of Pediatric Haematology, Faculty of Medicine, Cairo University, Cairo, Egypt., Hajipour M; Pediatric Gastroenterology, Hepatology and Nutrition Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Ansari SH; Children's Hospital Karachi (CHK), Karachi, Pakistan., Filosa A; Rare Blood Cell Disease Unit, 'Cardarelli' Hospital, Naples, Italy., Ceci A; Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, Valenzano (BA), Italy., Singer ST; Division of Hematology-Oncology, Department of Pediatrics, University of California San Francisco, UCSF Benioff Children's Hospital Oakland, Oakland, CA, USA., Naserullah ZA; Dammam Maternity and Child Hospital, Dammam, Saudi Arabia., Pepe A; Institute of Radiology, Department of Medicine, University of Padua, Italy., Cademartiri F; Department of Radiology, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy., Pollina SA; D.A.S.O.E, Regione Siciliana, Palermo, Italy., Scondotto S; D.A.S.O.E, Regione Siciliana, Palermo, Italy., Dardanoni G; D.A.S.O.E, Regione Siciliana, Palermo, Italy., Bonifazi F; Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, Valenzano (BA), Italy., Sankaran VG; Division of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Harvard Stem Cell Institute, Cambridge, MA, USA., Vichinsky E; Division of Hematology-Oncology, Department of Pediatrics, University of California San Francisco, UCSF Benioff Children's Hospital Oakland, Oakland, CA, USA., Taher AT; Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon., Maggio A; Campus of Haematology Franco and Piera Cutino, AOOR Villa Sofia-V. Cervello, Palermo, Italy. Electronic address: md.amaggio@gmail.com.

Publikováno v: Blood cells, molecules & diseases [Blood Cells Mol Dis] 2023 Mar; Vol. 99, pp. 102710. Date of Electronic Publication: 2022 Nov 25.

Primary HBB gene mutation severity and long-term outcomes in a global cohort of β-thalassaemia.

Autor: Musallam KM; Thalassemia Center, Burjeel Medical City, Abu Dhabi, United Arab Emirates., Vitrano A; Campus of Haematology Franco and Piera Cutino, AOOR Villa Sofia-V. Cervello, Palermo, Italy., Meloni A; MRI Unit, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy., Addario Pollina S; D.A.S.O.E, Regione Siciliana, Palermo, Italy., Di Marco V; Department of Promozione della Salute, Materno Infantile, Medicina Interna e Specialistica di Eccellenza (PROMISE), University of Palermo, Palermo, Italy., Hussain Ansari S; Department of Pediatric Haematology & Molecular Medicine, National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan., Filosa A; Rare Blood Cell Disease Unit, 'Cardarelli' Hospital, Naples, Italy., Ricchi P; Rare Blood Cell Disease Unit, 'Cardarelli' Hospital, Naples, Italy., Ceci A; Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, Valenzano (BA), Italy., Daar S; Department of Haematology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Sultanate of Oman.; Wallenberg Research Centre, Stellenbosch Institute for Advanced Study, Stellenbosch University, Stellenbosch, South Africa., Vlachaki E; Thalassaemia Unit, Ippokratio University Hospital, Thessaloniki, Greece., Singer ST; Division of Hematology-Oncology, Department of Pediatrics, University of California San Francisco, UCSF Benioff Children's Hospital Oakland, Oakland, CA, USA., Naserullah ZA; Dammam Maternity and Child Hospital, Dammam, Saudi Arabia., Pepe A; MRI Unit, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy., Scondotto S; D.A.S.O.E, Regione Siciliana, Palermo, Italy., Dardanoni G; D.A.S.O.E, Regione Siciliana, Palermo, Italy., Karimi M; Haematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., El-Beshlawy A; Department of Pediatric Haematology, Faculty of Medicine, Cairo University, Cairo, Egypt., Hajipour M; Pediatric Gastroenterology, Hepatology and Nutrition Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Bonifazi F; Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, Valenzano (BA), Italy., Vichinsky E; Division of Hematology-Oncology, Department of Pediatrics, University of California San Francisco, UCSF Benioff Children's Hospital Oakland, Oakland, CA, USA., Taher AT; Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon., Sankaran VG; Division of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Stem Cell Institute, Cambridge, MA, USA., Maggio A; Campus of Haematology Franco and Piera Cutino, AOOR Villa Sofia-V. Cervello, Palermo, Italy.

Publikováno v: British journal of haematology [Br J Haematol] 2022 Jan; Vol. 196 (2), pp. 414-423. Date of Electronic Publication: 2021 Oct 25.

A complication risk score to evaluate clinical severity of thalassaemia syndromes.

Autor: Vitrano A; Campus of Haematology Franco and Piera Cutino, AOOR Villa Sofia-V. Cervello, Palermo, Italy., Meloni A; U.O.C. MRI, Fondazione Toscana G. Monasterio, Pisa, Italy., Addario Pollina W; D.A.S.O.E, Regione Siciliana, Palermo, Italy., Karimi M; Haematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., El-Beshlawy A; Cairo University, Giza, Egypt., Hajipour M; Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Di Marco V; Sezione di Gastroenterologia e Epatologia, Dipartimento Biomedico di Medicina Interna e Specialistica, University of Palermo, Palermo, Italy., Hussain Ansari S; Department of Paediatric Haematology and Molecular Medicine, National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan., Filosa A; Rare Blood Cell Disease Unit, 'Cardarelli' Hospital, Naples, Italy., Ricchi P; Rare Blood Cell Disease Unit, 'Cardarelli' Hospital, Naples, Italy., Ceci A; Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, Valenzano, BA, Italy., Daar S; Department of Haematology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Sultanate of Oman.; Wallenberg Research Centre, Stellenbosch Institute for Advanced Study, Stellenbosch University, Stellenbosch, South Africa., Titi Singer S; Haematology/Oncology Department, Oakland, CA, USA., Naserullah ZA; Dammam Maternity and Child Hospital, Dammam, Saudi Arabia., Pepe A; U.O.C. MRI, Fondazione Toscana G. Monasterio, Pisa, Italy., Scondotto S; D.A.S.O.E, Regione Siciliana, Palermo, Italy., Dardanoni G; D.A.S.O.E, Regione Siciliana, Palermo, Italy., Bonifazi F; Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, Valenzano, BA, Italy., Vichinsky E; Haematology/Oncology Department, Oakland, CA, USA., Maggio A; Campus of Haematology Franco and Piera Cutino, AOOR Villa Sofia-V. Cervello, Palermo, Italy.

Publikováno v: British journal of haematology [Br J Haematol] 2021 Feb; Vol. 192 (3), pp. 626-633. Date of Electronic Publication: 2020 Nov 20.

Hemoglobin A 2 (HbA 2 ) has a measure of unreliability in diagnosing β-thalassemia trait (β-TT).

Autor: Al-Amodi AM; a Department of Genetic Research , Institute for Research and Medical Consultation (IRMC), Imam Abdulrahman Bin Faisal University , Dammam , Saudi Arabia., Ghanem NZ; a Department of Genetic Research , Institute for Research and Medical Consultation (IRMC), Imam Abdulrahman Bin Faisal University , Dammam , Saudi Arabia., Aldakeel SA; a Department of Genetic Research , Institute for Research and Medical Consultation (IRMC), Imam Abdulrahman Bin Faisal University , Dammam , Saudi Arabia., Ibrahim Al Asoom L; b Department of Physiology, College of Medicine , Imam Abdulrahman Bin Faisal University , Dammam , Saudi Arabia., Rafique Ahmed N; b Department of Physiology, College of Medicine , Imam Abdulrahman Bin Faisal University , Dammam , Saudi Arabia., Almandil NB; c Department of Clinical Pharmacy Research , Institute for Research and Medical Consultation (IRMC), Imam Abdulrahman Bin Faisal University , Dammam , Saudi Arabia., Naserullah ZA; d Dammam Maternity and Child Hospital , Dammam , Saudi Arabia., Al-Jarrash S; d Dammam Maternity and Child Hospital , Dammam , Saudi Arabia., Shakil Akhtar M; e Department of Biochemistry , Imam Abdulrahman Bin Faisal University , Dammam , Saudi Arabia., AbdulAzeez S; a Department of Genetic Research , Institute for Research and Medical Consultation (IRMC), Imam Abdulrahman Bin Faisal University , Dammam , Saudi Arabia., Al-Ali AK; e Department of Biochemistry , Imam Abdulrahman Bin Faisal University , Dammam , Saudi Arabia., Borgio JF; a Department of Genetic Research , Institute for Research and Medical Consultation (IRMC), Imam Abdulrahman Bin Faisal University , Dammam , Saudi Arabia.

Publikováno v: Current medical research and opinion [Curr Med Res Opin] 2018 May; Vol. 34 (5), pp. 945-951. Date of Electronic Publication: 2018 Feb 15.

KLF1 gene and borderline hemoglobin A 2 in Saudi population.

Autor: Borgio JF; Department of Genetic Research, Institute for Research and Medical Consultation (IRMC), University of Dammam, Dammam, Saudi Arabia., AbdulAzeez S; Department of Genetic Research, Institute for Research and Medical Consultation (IRMC), University of Dammam, Dammam, Saudi Arabia., Al-Muslami AM; Department of Genetic Research, Institute for Research and Medical Consultation (IRMC), University of Dammam, Dammam, Saudi Arabia., Naserullah ZA; Dammam Maternity and Child Hospital, Dammam, Saudi Arabia., Al-Jarrash S; Dammam Maternity and Child Hospital, Dammam, Saudi Arabia., Al-Suliman AM; Al-Omran Scientific Chair for Hematological Diseases Prevalent in the Al-Ahssa Area, King Faisal University, Al-Ahssa, Saudi Arabia., Al-Madan MS; Department of Pediatrics, King Fahd Hospital of the University, Al-Khobar, Saudi Arabia., Al-Ali AK; Department of Biochemistry, University of Dammam, Dammam, Saudi Arabia.

Publikováno v: Archives of medical science : AMS [Arch Med Sci] 2018 Jan; Vol. 14 (1), pp. 230-236. Date of Electronic Publication: 2017 Dec 19.